Cargando…

Combinatorial targeting of multiple myeloma by complementing T cell engaging antibody fragments

Bispecific T cell engaging antibodies (BiTEs) address tumor associated antigens that are over-expressed on cancer but that can also be found on healthy tissues, causing substantial on-target/off-tumor toxicities. To overcome this hurdle, we recently introduced hemibodies, a pair of complementary ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geis, Maria, Nowotny, Boris, Bohn, Marc-Dominic, Kouhestani, Dina, Einsele, Hermann, Bumm, Thomas, Stuhler, Gernot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794243/ https://www.ncbi.nlm.nih.gov/pubmed/33420283 http://dx.doi.org/10.1038/s42003-020-01558-0

Ejemplares similares

Variant signaling topology at the cancer cell–T-cell interface induced by a two-component T-cell engager
por: Kouhestani, Dina, et al.
Publicado: (2020)

On-target restoration of a split T cell-engaging antibody for precision immunotherapy
por: Banaszek, Agnes, et al.
Publicado: (2019)

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab
por: Einsele, Hermann, et al.
Publicado: (2016)

Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma
por: Zhou, Xiang, et al.
Publicado: (2020)

P829: GENOMIC PROFILING IN CFDNA COMPLEMENTS MOLECULAR DIAGNOSIS IN PATIENTS WITH MULTIPLE MYELOMA
por: Schilhabel, Anke, et al.
Publicado: (2023)

The Urgent Need for Precision Medicine in Cancer and Its Microenvironment: The Paradigmatic Case of Multiple Myeloma
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors—A Retrospective Study
por: Neuchel, Christine, et al.
Publicado: (2017)

Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody
Publicado: (1983)

Production and Characterization of Human Monoclonal Antibody Fab Fragments to Vaccinia Virus from a Phage-Display Combinatorial Library()
por: Schmaljohn, Connie, et al.
Publicado: (1999)

P836: ANTIBODY-DRUG CONJUGATES AS POTENTIAL CAR-T CELL SPECIFIC OFF-SWITCH IN MULTIPLE MYELOMA
por: Bielowski, Anna, et al.
Publicado: (2023)

The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective
por: San-Miguel, Jesus F., et al.
Publicado: (2016)

Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments
por: Ohmuro-Matsuyama, Yuki, et al.
Publicado: (2013)

BCMA loss in the epoch of novel immunotherapy for multiple myeloma: from biology to clinical practice
por: Zhou, Xiang, et al.
Publicado: (2022)

Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
por: Kocaata, Zeki, et al.
Publicado: (2022)

Novel Bifunctional Single-Chain Variable Antibody Fragments to Enhance Virolysis by Complement: Generation and Proof-of-Concept
por: Huber, Georg, et al.
Publicado: (2014)

P808: CONTROLLED FRATRICIDE TO AUGMENT ANTI-MYELOMA REACTIVITY OF SLAMF7 AND CD38 CAR T CELLS
por: Konetzki, Verena, et al.
Publicado: (2023)

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
por: Rodríguez-Lobato, Luis Gerardo, et al.
Publicado: (2020)

Galileo: Three-dimensional searching in large combinatorial fragment spaces on the example of pharmacophores
por: Meyenburg, Christian, et al.
Publicado: (2022)

The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78
por: Rasche, Leo, et al.
Publicado: (2013)

Activation of the classical pathway of complement by Hageman factor fragment
Publicado: (1981)

Luciferase fragment complementation imaging in preclinical cancer studies
por: Lake, Madryn C., et al.
Publicado: (2014)

Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment‐Based Drug Design Facilitated by Dynamic Combinatorial Chemistry
por: Mondal, Milon, et al.
Publicado: (2016)

A Combinatory Antibody–Antigen Microarray Assay for High-Content Screening of Single-Chain Fragment Variable Clones from Recombinant Libraries
por: Persson, Nina, et al.
Publicado: (2016)

Both APRIL and antibody-fragment-based CAR T cells for myeloma induce BCMA downmodulation by trogocytosis and internalization
por: Camviel, Nicolas, et al.
Publicado: (2022)

Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma
por: Steinhardt, Maximilian Johannes, et al.
Publicado: (2020)

Extremal combinatorial problems and their applications
por: Stechkin, Boris S, et al.
Publicado: (1995)

Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature
por: Danhof, Sophia, et al.
Publicado: (2015)

Recombining Low Homology, Functionally Rich Regions of Bacterial Subtilisins by Combinatorial Fragment Exchange
por: Jones, D. Dafydd
Publicado: (2011)

Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches
por: Pathan, Akbar Ali Khan, et al.
Publicado: (2016)

Conference on Combinatorial Mathematics and its Applications
por: Welsh, Dominic J A
Publicado: (1971)

The opsonic fragment of the third component of human complement (C3)
Publicado: (1975)

Complementation between inactive fragments of SssI DNA methyltransferase
por: Ślaska-Kiss, Krystyna, et al.
Publicado: (2012)

The influence of baseline characteristics, treatment and depression on health-related quality of life in patients with multiple myeloma: a prospective observational study
por: Fischer, Julia, et al.
Publicado: (2022)

Teclistamab-cqyv: The First Bispecific T-Cell Engager Antibody for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
por: Hua, Gwen, et al.
Publicado: (2023)

Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates
por: Kim, Eunhee G., et al.
Publicado: (2020)

Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management Strategies
por: Zhou, Xiang, et al.
Publicado: (2020)

Data Correcting Approaches in Combinatorial Optimization
por: Goldengorin, Boris, et al.
Publicado: (2012)

Complement C3 and Activated Fragment C3a Are Involved in Complement Activation and Anti-Bacterial Immunity
por: Wu, Meng, et al.
Publicado: (2022)

Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches [Corrigendum]
Publicado: (2017)

Viral interference with antibody and complement
por: Lubinski, John, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_q59036j24ihe0vu109db484d0l